Non-invasive focused ultrasound reduces craving in opioid use disorde
28.02.25EPFL
Opioid use disorder is a major healthcare challenge in the US and an emerging challenge across Europe, with current treatments often falling short in preventing relapse. A study led by our close collaborators at Rockefeller Neuroscience Institute (Prof. Ali Rezai, West-Virginia University, US) explored the safety and feasibility of focused ultrasound (FUS) neuromodulation as a potential new approach to reduce substance cravings and use in individuals with severe opioid and co-occurring substance use disorders.